Nikhil Prasad Fact checked by:Thailand Medical News Team Jan 03, 2025 2 days, 3 hours, 43 minutes ago
Medical News: Introduction to Melatonin and Tumor Necrosis Factor
Chronic inflammation is a condition that affects millions of people globally, often leading to debilitating diseases like rheumatoid arthritis, lupus, and even neurodegenerative disorders such as Alzheimer's. At the heart of this inflammatory response lies a molecule called Tumor Necrosis Factor (TNF), a protein produced by immune cells. While TNF plays a critical role in defending the body against infections and cancer, its overproduction can cause serious damage. Existing therapies aim to neutralize TNF but often come with significant side effects, such as immunosuppression and increased susceptibility to infections and cancers.
Melatonin Shows Promise in Controlling Chronic Inflammation
In an exciting development, researchers have turned their attention to melatonin, a molecule best known for regulating sleep. Produced by the pineal gland, melatonin has been found to have powerful antioxidant and anti-inflammatory properties. A new review of studies led by scientists from the Instituto de Biomedicina de Sevilla (IBiS), Universidad de Sevilla in Spain, and Universidad Católica de Cuenca in Ecuador explores how melatonin might be a safer alternative to conventional TNF therapies. This
Medical News report delves into the findings and implications of their research.
The Study in Focus
The review analyzed 45 studies, comprising 23 in vitro experiments on human cells and 22 in vivo studies involving human participants. It aimed to evaluate melatonin’s effectiveness in modulating TNF levels and its potential as an anti-inflammatory agent. According to the researchers, melatonin not only reduces TNF production but also comes with added benefits like low toxicity, affordability, and the ability to cross the blood-brain barrier - an important feature for treating neuroinflammatory conditions.
The researchers from the Instituto de Biomedicina de Sevilla and Universidad de Sevilla focused on human-based studies to ensure the findings are directly relevant to clinical applications. They emphasized the need for rigorous clinical trials to unlock melatonin’s full potential as a therapy for TNF-related conditions.
How Melatonin Works
Melatonin’s ability to modulate inflammation lies in its dual role as an antioxidant and immunomodulator. It acts as an "immune buffer," suppressing excessive immune responses while stimulating immunity when needed. This balancing act makes it uniquely suited to manage conditions involving chronic inflammation.
Melatonin achieves its effects through multiple mechanisms:
-Inhibiting NF-κB Pathway: This pathway is central to the production of inflammatory molecules, including TNF. Melatonin blocks NF-κB’s activation, thereby reducing inflammation.
-Scavenging Free Radicals: By neutralizing reactive oxygen species, melatonin prevents oxidative damage that exacerbates infl
ammation.
-Boosting Antioxidant Defense: It activates protective pathways like Nrf2, which further mitigates inflammatory damage.
Key Findings from the Review
-In Vitro Studies: Laboratory experiments demonstrated that melatonin significantly reduced TNF production in human cells exposed to inflammatory triggers such as bacterial toxins and oxidative stress. For instance, melatonin lowered TNF levels in cells treated with lipopolysaccharides (a component of bacterial cell walls), a common model for studying inflammation.
-In Vivo Studies: Human trials confirmed these findings. Melatonin supplementation reduced TNF levels in patients with conditions ranging from obesity and polycystic ovary syndrome to neurodegenerative diseases like Parkinson’s. In patients undergoing coronary artery bypass surgery, melatonin not only decreased TNF but also improved recovery by reducing oxidative stress.
-Neuroinflammatory Diseases: Perhaps most impressively, melatonin showed promise in treating neuroinflammatory conditions. Its ability to cross the blood-brain barrier allows it to directly target inflammation within the brain. This is a significant advantage over existing TNF inhibitors, which struggle to penetrate the brain’s protective barrier.
Implications for Chronic Disease Management
Melatonin’s versatility makes it a compelling candidate for managing various chronic diseases:
-Autoimmune Diseases: Conditions like rheumatoid arthritis and lupus often involve high TNF levels. Melatonin’s dual action of reducing TNF and mitigating oxidative stress could offer relief without the severe side effects of current therapies.
-Neurodegenerative Disorders: By reducing brain inflammation, melatonin might slow the progression of diseases like Alzheimer’s and Parkinson’s.
-Cancer-Associated Inflammation: Melatonin’s role in modulating TNF levels could help alleviate cancer cachexia (wasting syndrome) while supporting the immune system’s fight against tumors.
Limitations and Future Directions
While the findings are promising, the researchers stress that more clinical trials are needed to fully understand melatonin’s potential and optimize its use. Current studies vary widely in dosage and treatment duration, making it difficult to establish standardized guidelines. Additionally, melatonin’s effects may differ based on individual factors like age, disease severity, and concurrent medications.
Conclusion
The research underscores melatonin’s potential as a groundbreaking therapy for conditions involving chronic inflammation. Its unique combination of low toxicity, affordability, and ability to modulate the immune response makes it an attractive alternative to traditional TNF inhibitors. As the authors note, improving our understanding of melatonin’s mechanisms through well-designed clinical trials could revolutionize how we treat a host of inflammatory diseases. This molecule, often overlooked as a mere sleep aid, might hold the key to safer and more effective treatments for millions of patients worldwide.
The study findings were published in the peer-reviewed journal: Journal of Pineal Research.
https://onlinelibrary.wiley.com/doi/10.1111/jpi.70025
For the latest on Melatonin, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/melatonin-could-be-key-in-protecting-the-brain-from-rsv-induced-damage
https://www.thailandmedical.news/news/melatonin-and-gut-health
https://www.thailandmedical.news/news/melatonin-a-potential-ally-for-heart-and-vascular-health
https://www.thailandmedical.news/news/melatonin-a-potential-game-changer-in-arthritis-treatment
https://www.thailandmedical.news/news/melatonin-alleviates-acute-exacerbation-of-copd-induced-by-influenza-virus-infection-by-inhibiting-m1-macrophage-polarization-and-apoptosis
https://www.thailandmedical.news/news/mexican-study-shows-that-melatonin-can-restore-redox-homeostasis-alteration-in-covid-19-patients
https://www.thailandmedical.news/news/melatonin-supplements-can-cause-gut-inflammation-and-increase-severity-of-crohn-s-disease-and-ulcerative-colitis-depending-on-microbiota-profile
https://www.thailandmedical.news/news/latest-new-study-reveals-that-melatonin-supplements-can-aid-in-treating-certain-long-covid-symptoms
https://www.thailandmedical.news/news/melatonin-covid-19-columbia-university-study-shows-that-melatonin-increases-survival-rates-of-covid-19-patients-on-ventilators
https://www.thailandmedical.news/news/melatonin-and-covid-19:-more-studies-emerging-that-melatonin-is-useful-as-an-adjuvant-treatment-for-covid-19-due-to-its-anti-inflammatory-properties-
https://www.thailandmedical.news/news/breaking-covid-19-supplements-melatonin-helps-lessen-severity-risk-in-covid-19-patients-by-preventing-cytokine-storms
https://www.thailandmedical.news/news/study-shows-that-melatonin-based-drugs-inhibit-sars-cov-2-entry-into-the-brain-and-prevent-damage-of-cerebral-vessels-might-be-good-for-long-covid
https://www.thailandmedical.news/news/covid-19-supplements-yet-another-study-indicates-that-melatonin-can-prevent-severe-covid-19
https://www.thailandmedical.news/news/covid-19-supplements-cleveland-clinic-study-highlights-efficacy-of-melatonin-to-help-treat-covid-19
Share
Tweet
Share
